Clinical predictors of heart failure in patients with first acute myocardial infarction

American Heart Journal

Volumn 138, Issue 6 I, 1999, Pages 1133-1139

  Ali, A S ^a   Rybicki, B A ^a   Alam, M ^a   Wulbrecht, N ^a   Richer Cornish, K ^a   Khaja, F ^a   Sabbah, H N ^a   Goldstein, S ^a  

^a Henry Ford Heart/Vascular Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0032759179     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70080-3     Document Type: Article

References (20)

1. Kostis JB, Davis BR, Cutler J, Grimm RH, Berge KG, Cohen JD, et al for the SHEP Cooperative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997;278:212-6.
2. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993;22(suppl A):6A-13A.
3. Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med 1990;322:743-53.
4. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-62.
5. Ward SR, Sutton JM, Pieper KS, Schwaiger M, Califf RM, Topol EJ. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. Am J Cardiol 1997;79:539-44.
6. O'Connor CM, Hathaway WR, Bates E, Leimberger JD, Sigmon KN, Kereiakes DJ, et al. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. Am Heart J 1997;133:563-73.
7. Herlitz J, Waagstein F, Lindqvist J, Swedberg K, Hjalmarson A. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial). Am J Cardiol 1997;80:40-4.
8. Gadsboll K, Hoilund-Carlsen, Nielsen CG, Berning J, Brunn NE, Hein SE, et al. Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest xray, radionuclide ventriculography and right heart catheterization. Eur Heart J 1989;9;1017-28.
9. Kinugawa T, Dibner-Dunlap ME. Altered vagal and sympathetic control of heart rate in left ventricular dysfunction and heart failure. Am J Physiol 1995;268:R317-23.
10. McGovern P, Herlitz J, Pankow JS, Karlsson T, Dellborg M, Shahar E, et al. Comparison of medical care and 1 and 12 month mortality of hospitalized patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, United States of America and Goteborg, Sweden. Am J Cardiol 1997;80:557-62.
11. Rask-Madsen C, Jensent G, Kobert L, Melchiort T, Torp-Pedersent C, Hildebrands P. Age-related mortality, clinical heart failure, and ventricular fibrillation in 4259 Danish patients after acute myocardial infarction. Eur Heart J 1997;18:1426-31.
12. Emanuelsson H, Karlson BW, Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J 1994;15:761-8.
13. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). New Engl J Med 1992;327:678-84.
14. Kober L, Torp-Pedersen C, Carlsen JA, Bagger H, Eliasen P, Lyngborg K, et al for the Trandilopril Cardiac Evalaution (TRACE) Study Group. A clinical trial of the angiotensin converting enzyme inhibitor trandilopril in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 1995;333:1670-5.
15. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. New Engl J Med 1995;332:80-119.
16. Volpi A, DeVita C, Franzosi G, Geraci E, Maggioni AP, Mauri F, et al for the Ad Hoc Working Group of the Gruppo Italiano per lo Studio della Sopra Uvivenza nell Infarts Miocardico (GISSI)-2 data base. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. Circulation 1993;88:416-29.
17. Maynard C, Weaver WD, Litwin PE, Martin JS, Kudenshuk PJ, Dewhurst TA, et al. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (The Myocardial Infarction Triage And Intervention Project). Am J Cardiol 1993;72:L877-82.
18. Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction: lessons from overviews of recent randomized controlled trials. Circulation 1990;82(Suppl II):II-117-II-134.
19. DeMellow WC. Renin-angiotensin system and cell communication in the failing heart. Hypertension 1996;27:1267-72.
20. The MIAMI Trial Research Group. Metoprolol In Acute Myocardial Infarction (MIAMI): a randomized placebo-controlled international trial. Eur Heart J 1985;6:199-226.